Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2025
Client: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
Electrodiagnostic Patient Protection and Fraud Elimination Act, HR 3092, ALS Better Care Act (not yet introduced), medical research funding
Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2025
Client: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
Physician reimbursement, HR 3092
Electrodiagnostic Patient Protection and Fraud Elimination Act, HR 3092, ALS Better Care Act (not yet introduced), medical research funding
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
Electrodiagnostic Patient Protection and Fraud Elimination Act, HR 3092, ALS Better Care Act (not yet introduced), medical research funding
Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2025
Client: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
Electrodiagnostic Patient Protection and Fraud Elimination Act, HR 3092, ALS Better Care Act (not yet introduced), medical research funding
Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2025
Client: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
Physician reimbursement, HR 3092
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
Physician reimbursement, HR 879
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
Physician reimbursement, HR 879
To amend title XVIII of the Social Security Act to provide for additional requirements with respect to electrodiagnostic services under the Medicare program.
Client: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
Quality electrodiagnostic medicine - HR 8780
To amend title XVIII of the Social Security Act to provide for additional requirements with respect to electrodiagnostic services under the Medicare program.
Client: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
Quality electrodiagnostic medicine - HR 8780
Patients' Access to Treatments Act of 2015
Client: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
Electrodiagnostic Accreditation and reimbursement - creating mandatory standards for electrodiagnostic testing (needle EMG and nerve conduction studies) NIH funding of at least $32 billion for federal medical research Ensuring Access to Clinical Trials Act (S. 139/H.R. 209) - This legislation passed the Senate and needs to be passed by the House before financial incentives for patients to participate in rare disease clinical trials lapse later this year Patients Access to Treatments Act (H.R. 1600) - Some conditions diagnosed through EDX testing are progressive and treatment needs to begin as quickly as possible. Restrictive coinsurance requirements on innovative therapies create significant barriers for patients in need of life-changing therapies.
Ensuring Access to Clinical Trials Act of 2015
Client: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
Electrodiagnostic Accreditation and reimbursement - creating mandatory standards for electrodiagnostic testing (needle EMG and nerve conduction studies) NIH funding of at least $32 billion for federal medical research Ensuring Access to Clinical Trials Act (S. 139/H.R. 209) - This legislation passed the Senate and needs to be passed by the House before financial incentives for patients to participate in rare disease clinical trials lapse later this year Patients Access to Treatments Act (H.R. 1600) - Some conditions diagnosed through EDX testing are progressive and treatment needs to begin as quickly as possible. Restrictive coinsurance requirements on innovative therapies create significant barriers for patients in need of life-changing therapies.
Ensuring Access to Clinical Trials Act of 2015
Client: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
Electrodiagnostic Accreditation and reimbursement - creating mandatory standards for electrodiagnostic testing (needle EMG and nerve conduction studies) NIH funding of at least $32 billion for federal medical research Ensuring Access to Clinical Trials Act (S. 139/H.R. 209) - This legislation passed the Senate and needs to be passed by the House before financial incentives for patients to participate in rare disease clinical trials lapse later this year Patients Access to Treatments Act (H.R. 1600) - Some conditions diagnosed through EDX testing are progressive and treatment needs to begin as quickly as possible. Restrictive coinsurance requirements on innovative therapies create significant barriers for patients in need of life-changing therapies.
Patients' Access to Treatments Act of 2013
Client: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
- CMS reimbursement rate cuts for electrodiagnostic medicine in 2013 - H.R. 460 - support for patient's access to treatment to limit cost-sharing requirements applicable to medications in a specialty drug tier - Delay implementation of Sunshine Act to allow time for physicians to review. - Support permanent repeal of the Medicare Sustainable Growth Rate
Physician reimbursement, HR 879
Electrodiagnostic Patient Protection and Fraud Elimination Act, HR 3092, ALS Better Care Act (not yet introduced), medical research funding
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Physician reimbursement, HR 879
Electrodiagnostic Patient Protection and Fraud Elimination Act, HR 3092, ALS Better Care Act (not yet introduced), medical research funding
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Quality in electrodiagnostic medicine. Physician fee schedule.
Quality in electrodiagnostic medicine. Physician fee schedule.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Quality in electrodiagnostic medicine. Physician fee schedule.
Quality in electrodiagnostic medicine. Physician fee schedule.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Quality in electrodiagnostic medicine. Physician fee schedule.
Quality in electrodiagnostic medicine. Physician fee schedule.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Quality in electrodiagnostic medicine. Physician fee schedule.
Quality in electrodiagnostic medicine. Physician fee schedule.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Quality in electrodiagnostic medicine. Physician fee schedule.
Quality in electrodiagnostic medicine. Physician fee schedule.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Quality in electrodiagnostic medicine. Physician fee schedule.
Quality in electrodiagnostic medicine. Physician fee schedule.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Quality in electrodiagnostic medicine. Physician fee schedule.
Quality in electrodiagnostic medicine. Physician fee schedule.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Quality in electrodiagnostic medicine. Physician fee schedule.
Quality in electrodiagnostic medicine. Physician fee schedule.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Quality in electrodiagnostic medicine. Physician fee schedule
quality electrodiagnostic medicine. physician fee schedule
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Quality in electrodiagnostic medicine
quality electrodiagnostic medicine
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Quality in electrodiagnostic medicine
quality electrodiagnostic medicine
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Quality in electrodiagnostic medicine
quality electrodiagnostic medicine
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Telehealth, Medicare Sequester, quality in electrodiagnostic medicine
quality electrodiagnostic medicine, medicare sequester, telehealth coverage/reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
quality electrodiagnostic medicine, medicare sequester, telehealth coverage/reimbursement
Telehealth, Medicare Sequester, quality in electrodiagnostic medicine
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
quality electrodiagnostic medicine, medicare sequester, telehealth coverage/reimbursement
Telehealth, Medicare Sequester, quality in electrodiagnostic medicine
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
quality electrodiagnostic medicine, medicare sequester, telehealth coverage/reimbursement
Telehealth, Medicare Sequester, quality in electrodiagnostic medicine
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Quality electrodiagnostic medicine - HR 8780
Quality electrodiagnostic medicine - HR 8780
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Quality electrodiagnostic medicine
Quality electrodiagnostic medicineE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Quality electrodiagnostic medicine, PPE for medical professionals,
Quality electrodiagnostic medicine, NIH funding, stop efforts to require immediate "open access" to federally-funded research, access to PPE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Quality electrodiagnostic medicine, NIH funding, stop efforts to require immediate "open access" to federally-funded research
Quality electrodiagnostic medicine
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Quality electrodiagnostic medicine
Quality electrodiagnostic medicine
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Quality electrodiagnostic medicine
Quality electrodiagnostic medicine
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Quality electrodiagnostic medicine
Quality electrodiagnostic medicine
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Quality electrodiagnostic medicine
Quality electrodiagnostic medicine
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Standards for electrodiagnostic medicine. MACRA/QPP reform.
Standards for electrodiagnostic medicine. Reduce administrative burden of MACRA/QPP
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Standards for electrodiagnostic medicine. MACRA reform.
Standards for electrodiagnostic medicine. Reduce administrative burden of MACRA/QPP
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Standards for electrodiagnostic medicine. MACRA reform.
Standards for electrodiagnostic medicine. Reduce administrative burden of MACRA/QPP
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Standards for electrodiagnostic medicine. MACRA reform.
Standards for electrodiagnostic medicine. Reduce administrative burden of MACRA/QPP
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Standards for electrodiagnostic medicine. Reduce administrative burden of MACRA/QPP
Standards for electrodiagnostic medicine. MACRA reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Standards for electrodiagnostic medicine. NIH funding. MACRA reform.
Standards for electrodiagnostic medicine. Revise MACRA/administrative simplification of requirements.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Standards for electrodiagnostic medicine. Revise MACRA/administrative simplification of requirements.
Standards for electrodiagnostic medicine. NIH funding. MACRA reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Standards for electrodiagnostic medicine
Standards for electrodiagnostic medicine
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NIH Funding.
Urging CMS to work with AANEM on establishing minimum standards of care for electrodiagnostic medicine.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Urging CMS to work with AANEM on establishing minimum standards of care for electrodiagnostic medicine.
NIH Funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Urging CMS to work with AANEM on establishing minimum standards of care for electrodiagnostic medicine.
NIH Funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Urging CMS to work with AANEM on establishing minimum standards of care for electrodiagnostic medicine.
Filing targets: SENATE
Electrodiagnostic Accreditation and reimbursement - creating mandatory standards for electrodiagnostic testing (needle EMG and nerve conduction studies) NIH funding of at least $32 billion for federal medical research Ensuring Access to Clinical Trials Act (S. 139/H.R. 209) - This legislation passed the Senate and needs to be passed by the House before financial incentives for patients to participate in rare disease clinical trials lapse later this year Patients Access to Treatments Act (H.R. 1600) - Some conditions diagnosed through EDX testing are progressive and treatment needs to begin as quickly as possible. Restrictive coinsurance requirements on innovative therapies create significant barriers for patients in need of life-changing therapies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Electrodiagnostic Accreditation and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
2013 Medicare Fee Schedule
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
- CMS reimbursement rate cuts for electrodiagnostic medicine in 2013 - H.R. 460 - support for patient's access to treatment to limit cost-sharing requirements applicable to medications in a specialty drug tier - Delay implementation of Sunshine Act to allow time for physicians to review. - Support permanent repeal of the Medicare Sustainable Growth Rate
- CMS reimbursement cuts for electrodiagnostic medicine in 2013 and the impact they are having on quality electrodiagnostic providers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2013 Medicare Fee Schedule
2013 Medicare Fee Schedule
2013 Medicare Fee Schedule
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2013 Medicare Fee Schedule
Filing targets: HOUSE OF REPRESENTATIVES, SENATE